ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with Type 1 diabetes maintain their natural ability to produce insulin, slowing progression of the ...

Please provide your email address to receive an email when new articles are posted on . “In less-resource countries, the study estimates 35,000 young people under 25 years of age died in 2021 ...

A daily pill to help people newly diagnosed with type 1 diabetes, or those at risk of developing it, live without the ...

The positions in the table below reflect the Australian Centre for Behavioural Research in Diabetes (ACBRD)'s position overall, domestically, within their sector, and in various subject areas based on ...

An Australian study suggests that mandatory folic acid fortification may have unintended consequences, linking excess folate to rising gestational diabetes and calling for urgent policy reassessment.

No articles found. Australian Diabetes Society (ADS) did not contribute to any primary research papers from Nature Index journals in the current 12 month window. Represents joint institutions and ...

A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, Type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients ...